scispace - formally typeset
S

Simon J. L. Petitjean

Researcher at Université catholique de Louvain

Publications -  9
Citations -  495

Simon J. L. Petitjean is an academic researcher from Université catholique de Louvain. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 2, co-authored 2 publications receiving 179 citations.

Papers
More filters
Journal ArticleDOI

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.

TL;DR: It is demonstrated, both on model surfaces and on living cells, that the receptor binding domain (RBD) serves as the binding interface within the S-glycoprotein with the ACE2 receptor and the kinetic and thermodynamic properties of this binding pocket are extracted.
Journal ArticleDOI

Multivalent 9-O-Acetylated-sialic acid glycoclusters as potent inhibitors for SARS-CoV-2 infection

TL;DR: In this article , the role of sialic acids (SA) in early binding events of SARS-CoV-2 was studied using atomic force microscopy to study the early binding of the virus to the host cell.
Journal ArticleDOI

Stepwise Enzymatic-Dependent Mechanism of Ebola Virus Binding to Cell Surface Receptors Monitored by AFM.

TL;DR: This work used force-distance curve-based atomic force microscopy to quantify the binding between TIM-1/DC-SIGNR and EBOV glycoprotein (GP) and observed that both receptors specifically bind to GP with high-affinity.
Journal ArticleDOI

Salvia miltiorrhiza Bunge as a Potential Natural Compound against COVID-19

TL;DR: In vitro data demonstrate the potential of S. miltiorrhiza against COVID-19, consisting first of the blockade of the binding of SARS-CoV-2 to the ACE2 receptor and the mitigation of the inflammatory response from leukocytes by interfering with NFκB signaling, and prompts the launch of a clinical trial to address in vivo the clinical benefits of this promising agent.